Literature DB >> 2284513

Thymomas and thymic carcinomas.

A N Walker1, S E Mills, R E Fechner.   

Abstract

This review discusses epithelial proliferations of the thymus, excluding carcinoid tumor and small cell carcinoma. The clinical features of thymoma, possible etiologic mechanisms, and associated autoimmune and paraneoplastic conditions are summarized briefly. Histologic subtypes of thymoma, including lymphocyte predominant, mixed, and spindle cell tumors are described and illustrated. The concept of "medullary" and "cortical" differentiation in thymoma is reviewed. Immunohistochemical and electron microscopic features of this neoplasm are presented. Flow cytometric studies relating to its prognosis also are summarized. Distinctions between encapsulated thymoma, invasive thymoma, and metastatic or "malignant" thymoma are described in detail. Thymic carcinomas are reviewed, as distinguished from cytologically bland thymomas. Variants of thymic carcinoma include squamous cell, spindle cell, lymphoepithelioma-like, mucoepidermoid, adenosquamous, clear cell, basaloid, and adenoid cystic neoplasms.

Entities:  

Mesh:

Year:  1990        PMID: 2284513

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

1.  Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus.

Authors:  M Sarbia; C Loberg; M Wolter; J Arjumand; H Heep; G Reifenberger; H E Gabbert
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Pure basaloid squamous cell carcinoma of the uterine cervix: a case report.

Authors:  Yong Soon Kwon; Yong Man Kim; Ga Won Choi; Young Tak Kim; Joo-Hyun Nam
Journal:  J Korean Med Sci       Date:  2009-06-18       Impact factor: 2.153

3.  Primary thymic carcinoma with adenoid cystic carcinoma-like features: A case report and literature review.

Authors:  Mai-Qing Yang; Lin-Lin Bai; Zhao Wang; Wen-Jing Huang; Gui-Yang Jiang; Hong-Tao Xu
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.